Jindal Medicot Limited - healthcare in Ludhiana, Punjab, India. FY 2026 financials & compliance.
CIN U17100PB2008PLC031964 Incorporated 27 May 2008 ROC Chandigarh HQ Ludhiana, Punjab, India
Under Insolvency Public Limited Company healthcare
Data last updated
Revenue · FY 2024
₹6.81 Lakh
▼ 35% YoY
Net loss · FY 2024
₹5.66 Cr
Latest filing
EBITDA · FY 2024
-₹15.4 Lakh
EBITDA margin -226.1%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹7.4 Cr
Issued & subscribed
Open charges
₹99.77 Cr
Secured borrowings
Company age
18 yrs
Est. 2008
Employees · EPFO
74
Provident fund records

About Jindal Medicot Limited

Data last updated:

Jindal Medicot Limited is a public limited company based in Ludhiana, Punjab, India, a subsidiary of Jindal Technotex Limited. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 27 May 2008.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U17100PB2008PLC031964. The company has 3 GST registrations on record, none of which is active.

The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹7.4 Cr. It is led by directors including Sandeep Jindal and Alisha.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ludhiana, Punjab.

As per the financials filed for FY 2024, the company reported a revenue of ₹6.81 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹5.66 Cr and EBITDA of -₹15.4 Lakh (EBITDA margin -226.1%). Revenue has declined at a compounded annual rate (CAGR) of 87% over three years and 74% over five years.

The company has about 74 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹99.77 Cr on record. Court records list 24 cases involving the company, including 6 filed by the company and 18 filed against it; 3 cases are pending. The company has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹39 Cr; the latest was in March 2019.

The last known website on record is sjgroup.in.

Company details

CIN U17100PB2008PLC031964
Registration Number 031964
Incorporation Date 27 May 2008
ROC Chandigarh
Listing Status Unlisted
Company Status Under CIRP
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Jindal Technotex Limited
Compliance Status Active Compliant

Contact details

Jindal Medicot Limited's registered office is in Ludhiana, Punjab. Its website is sjgroup.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    Mandiala Kalan, P.O. Bija Teh Khanna India, Ludhiana, Punjab, India – 141412
  • Industry
    Healthcare, Medical Consumables & Supplies

To see the full contact details of Jindal Medicot Limited, buy the company report.

Comprehensive company report
Jindal Medicot Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Jindal Medicot is manufacturing. In detail, this covers textile, leather and other apparel products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC2Textile, leather and other apparel products

Financials of Jindal Medicot Limited

FY 2024 filings available

Jindal Medicot Limited reported revenue of ₹6.81 Lakh (down 35% YoY) for FY 2024.

Revenue · FY 2024
₹6.81 Lakh ▼ 35%
Net loss · FY 2024
₹5.66 Cr
EBITDA · FY 2024
-₹15.4 Lakh margin -226.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 35%
3 years · compounded
▼ 87%
5 years · compounded
▼ 74%
EBITDA CAGR growth
1 year
▼ 30%
3 years · compounded
▲ 83%
5 years · compounded
▼ 15%

Revenue has declined at a compounded annual rate (CAGR) of 74% over five years, including a 35% fall in the latest year. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹15.4 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5.66 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-226.1%
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Jindal Medicot Limited, buy the company report.

Board of directors of Jindal Medicot Limited

Jindal Medicot has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Sandeep JindalDirector27 May 200818 Years 4 MonthsAs last reported
AlishaDirector24 Jun 201610 Years 3 MonthsAs last reported
Kartar Chand DhimanDirector19 Dec 201114 Years 10 MonthsAs last reported

Auditor

Jindal Medicot Limited is audited by K R Aggarwal & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
K R Aggarwal & AssociatesFY 2023030088N

Shareholding

The shareholding of Jindal Medicot Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Jindal Medicot Limited, buy the company report.

Charges & borrowings

Open charges
₹99.77 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹66.55 Cr
Bank of Baroda₹18.52 Cr
Central Bank of India₹10.70 Cr
Punjab & Sind Bank₹4.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
03 Jan 201410474746Central Bank of India₹2 CrOpen
24 Nov 201210397272Central Bank of India₹70 LakhOpen
13 Aug 201110302980Central Bank of India₹8 CrOpen
26 Jul 201110301664Punjab & Sind Bank₹4 CrOpen
06 Jan 201010203389Bank of Baroda₹18.52 CrOpen

To see the full charge records of Jindal Medicot Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Jindal Medicot Limited has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹39 Cr; the latest was in March 2019.

Total deals
5
Secondary share transfers
3
Funding rounds
2
Disclosed funding
₹39 Cr

Deals on record (5 of 5)

WhenDealAmountParties
Mar 2019Secondary share transferUndisclosedBuyer: Jindal Technotex Limited
Seller: Jindal Cotex Limited
Jun 2018Secondary share transferUndisclosedBuyer: Jindal Cotex Limited & Anil Sharma, Jindal Cotex Limited & Rajesh Kumar Goyal
Seller: Jindal Cotex Limited & Manu Jindal, Jindal Cotex Limited & Santosh Jindal
Mar 2017Secondary share transferUndisclosedBuyer: Jindal Cotex Limited & Manu Jindal, Jindal Cotex Limited & Yash Paul Jindal & Sons Huf, Jindal Cotex Limited & Sandeep Jindal & Sons Huf
Seller: Jindal Cotex Limited & Rajinder Jindal, Jindal Cotex Limited & Geeta Jindal, Jindal Cotex Limited & Reen Prabha Jindal
Apr 2013Funding round₹9 CrInvestors: Jindal Holdings and Investment Limited
Mar 2010Funding round₹30 CrInvestors: Jindal Cotex Limited

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Jindal Medicot Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Jindal Medicot Limited has a workforce of 74 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.

Employee count
74
Active EPFO establishments
1
Employee growth
-7.5%

GST

Jindal Medicot has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
3
Cancelled / inactive
3

To see the full GST registrations and return filing status of Jindal Medicot Limited, buy the company report.

Recent activity

Jindal Medicot Limited has 13 board changes on record since 2008: 3 appointments and 10 cessations. The latest: Aman Jindal ceased to be Director on 14 Nov 2016.

AGM
Jindal Medicot Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Jindal Medicot Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Ceased
Aman Jindal ceased to be Director.
Ceased
Rajinder Kumar Jindal ceased to be Director.
Ceased
Ramesh Kumar Jindal ceased to be Director.
Ceased
Sahil Jindal ceased to be Director.
Ceased
Yash Paul Jindal ceased to be Director.
Ceased
Alisha ceased to be Additional Director.
Appointed
Alisha was appointed as Director.
Ceased
Nisha Rani ceased to be Additional Director.
Ceased
Rajesh Khanna ceased to be Director.
Ceased
Nirmal Kumar Jain ceased to be Director.

13 earlier events are in the company report.

Frequently asked questions

Jindal Medicot is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.

Jindal Medicot is a company under insolvency, formerly operating as a public limited company based in Ludhiana, Punjab, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 27 May 2008 and is registered under CIN U17100PB2008PLC031964. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

Jindal Medicot has 3 current directors:

The latest financial statements of Jindal Medicot on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Jindal Medicot is U17100PB2008PLC031964. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Jindal Medicot has open charges of ₹99.77 Cr and no satisfied charges on record as per latest MCA filings.

Jindal Medicot has 24 court cases on record: 6 filed by the company and 18 filed against it. 3 are pending. Most are in the district courts.

Jindal Medicot was incorporated on 27 May 2008. It is registered with the Registrar of Companies, Chandigarh.

Jindal Medicot has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹39 Cr; the latest was in March 2019.

Aman Jindal ceased to be Director on 14 Nov 2016. Rajinder Kumar Jindal ceased to be Director on 14 Nov 2016. Ramesh Kumar Jindal ceased to be Director on 14 Nov 2016. Jindal Medicot has 13 board changes on record in total.